Researchers at the University of Pittsburgh say a new minimally invasive intervention can target the root cause of neural function loss.

An infant with a fatal genetic disease has survived past the age of 2 with no signs of the condition, thanks to treatment ...

The evolution of functional assessments for spinal muscular atrophy (SMA) highlights the challenges of adapting pediatric ...

MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...

Spinal muscular atrophy (SMA) is a debilitating genetic condition that’s usually fatal by a few years of age. But an ...

Lower back pain affects millions of people every year. About 80% of people will experience back pain at some point in their ...

A new study shows that enhancing activity of a specific component of 'NMDA' receptors normalizes protein synthesis, neural activity and seizure susceptibility in the hippocampus of fragile X lab mice.

Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...

A toddler was successfully treated for a rare genetic disease, spinal muscular atrophy, after world-first in-womb therapy.

Content by RegenND Naturopathic Clinic. From tennis elbow and Achilles tendonitis to osteoarthritis and rotator cuff injuries ...

These various tests are at different stages of validation – assuring they’re accurate across many different populations. And, for each protein, there are several different met ...